tirzepatide osa SURMOUNTs obstructive sleep apnea, what's next in advancing GLP-1s? Clinical Impact of Tirzepatide on

However, these side effects were generally mild and resolved over time

CD22: CD22 (also known as Siglec-2) is a receptor belonging to the immunoglobulin superfamily, predominantly expressed on immature and mature B cells, but not on plasma cells (141)

While these medications may improve self-esteem and body confidence for some people, the sudden alterations in appearance could provoke or worsen BDD symptoms, potentially resulting in increased anxiety, depression and suicidal ideation

For some people, a stable, lower-than-maximum maintenance dose may strike an acceptable balance of efficacy and tolerability

Professional Monitoring is Key Always work with a qualified healthcare provider to monitor your progress, adjust dosing, and ensure safety

[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Hall KD, Sacks G, Chandramohan D, Chow CC, Wang YC, Gortmaker SL, Swinburn BA